Viral infections are one of the leading causes of morbidity and mortality worldwide and one of the main reasons for significant economic losses.7−9 Standard treatment approaches mainly rely on vaccination and therapeutics derived through targeting key processes in the virus life cycle. However, many viruses evolve subject to selective pressures, often becoming drug resistant, which necessitates additional resources for the development of new drugs.